BETHESDA, Md.--(BUSINESS WIRE)--Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that it will host a conference call and audio webcast to review its second quarter 2010 results on Thursday, August 5, 2010, at 8:30 AM ET.
